US consumer spending on CBD treatments for domestic pets jumped from $26 million in 2020 to $629 million in 2021, and is anticipated to grow to more than $1 billion by 2025 according to a Brightfield report. As pet owners continue to search for cheaper, more natural ways to treat chronic health issues in their animals, CBD is one of the first products they are turning to.
A host of publicly traded companies are leading the charge to develop these CBD-based treatments. Endexx (OTC:EDXC) is one company that has released both its line of Phyto Drops and Phyto Bites CBD treatments for pets to treat pet anxieties, as well as reducing inflammation and chronic pain. Other stocks like Charlotte’s Web (OTC:CWBHF) and Canopy Growth (NASDAQ:CGC) are also great plays for the booming pet CBD market.
$EDXC $CWBHF $CGC